Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04219189 · ClinicalTrials.gov registry record · NA

The Acute Effect of Vaping on Food Intake

A NA study of E-Cig Use and Appetite, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04219189 is a NA study of E-Cig Use and Appetite that has completed, run by Virginia Commonwealth University. The registered enrollment target is 40 participants, below the 147-participant average among 9 other E-Cig Use trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04219189, a NA study of E-Cig Use and Appetite, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study assesses the acute effects of a standardized 20-minute vaping episode compared to a non-vaping control condition on ad libitum food intake during a 30-minute buffet meal, occurring approximately 45 minutes after the vaping episode

Interventions

  • OTHER Control condition
  • OTHER Vaping condition

Study Locations (1)

Virginia

  • Center for the Study of Tobacco Products - Richmond

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-09-22
Est. Completion 2022-09-21
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT04219189

The ClinicalTrials.gov registry entry for NCT04219189 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 147-participant average among 9 other E-Cig Use trials with a reported enrollment target (73% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with E-Cig Use appearing as the primary indexed condition, and to 2 interventions - of which Control condition is the first listed.

NCT04219189 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT04219189 about?

NCT04219189 is a clinical study titled "The Acute Effect of Vaping on Food Intake". This study assesses the acute effects of a standardized 20-minute vaping episode compared to a non-vaping control condition on ad libitum food intake during a 30-minute buffet meal, occurring approximately 45 minutes after the vaping episode

What is the current status of trial NCT04219189?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-09-22. Estimated completion is 2022-09-21.

What conditions does trial NCT04219189 study?

This clinical trial studies the following conditions: E-Cig Use, Appetite, Energy Intake, Food Intake.

What interventions are being tested in trial NCT04219189?

The interventions under investigation include: Control condition (OTHER), Vaping condition (OTHER).

Who is sponsoring clinical trial NCT04219189?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04219189 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for E-Cig Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.